An official website of the United States government
NIH Guide: Weekly Index for October 6, 2023
Weekly NIH Funding Opportunities and Notices
October 6, 2023
Policy Notices
-
NIH Operates Under a Continuing Resolution
(NOT-OD-24-007)National Institutes of Health
General Notices
-
Notice of Pre-Application Webinar for RFA-CA-23-039 and RFA-CA-23-040 for the National Cancer Institute "Human Tumor Atlas Network (HTAN)" Program
(NOT-CA-23-095)National Cancer Institute
-
RESCINDED - Notice of Information: Upcoming Prize Competition Announcement for the 2024 DEBUT Challenge
(NOT-EB-23-023)National Institute of Biomedical Imaging and Bioengineering
-
Notice of Informational Webinar on the NIH Advancing Research Careers (ARC) Program Notices of Funding Opportunity (F99/K00 and UE5)
(NOT-GM-24-002)National Institute of General Medical Sciences
-
Notice of Availability of Frequently Asked Questions (FAQs) for NOT-HL-23-083 "Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities"
(NOT-HL-23-091)National Heart, Lung, and Blood Institute
-
Notice of NHLBI Participation in NOT-MD-23-002 Notice of Special Interest (NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations
(NOT-HL-23-119)National Heart, Lung, and Blood Institute
-
Notice of Participation of FIC in RFA-HD-24-009, "Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATCH-IN) 2"
(NOT-TW-23-008)John E. Fogarty International Center
-
Request for Information (RFI) on the need for research studies to evaluate potential effects of types of blood pressure reducing agents on the development of mild cognitive impairment and dementia
(NOT-AG-23-039)National Institute on AgingNational Heart, Lung, and Blood Institute
-
Request for Information (RFI): Environmental Justice Research Gaps, Opportunities and Capacity Building
(NOT-ES-23-016)National Institute of Environmental Health SciencesNational Cancer InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences ResearchOffice of Disease PreventionNational Institute on Minority Health and Health Disparities
-
Request for Information (RFI): Exploring the role of Generative AI in enhancing the use of Big Data in Heart, Lung, Blood, and Sleep (HLBS) research.
(NOT-HL-23-097)National Heart, Lung, and Blood Institute
-
Request for Information (RFI): Best Practices for Sharing NIH Supported Research Software
(NOT-OD-24-005)Office of the Director, NIH
Notice of Changes to Funding Opportunities
-
Notice of Change to Key Dates Listed in RFA-AG-24-027, "Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed)"
(NOT-AG-23-056)National Institute on Aging
-
Notice of Change to Key Dates Listed in RFA-AG-24-046, "Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed)"
(NOT-AG-23-057)National Institute on Aging
-
Notice of Change to Key Dates Listed in PAR-23-274, "Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD)(UG3/UH3 Clinical Trial Required)"
(NOT-AG-23-058)National Institute on Aging
-
Notice of Change to RFA-HD-24-010 "National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional)"
(NOT-HD-23-026)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Extension of the Expiration Date for PAR-21-115 Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
(NOT-HD-23-033)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Participation of NIMHD in PAR-23-292, Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
(NOT-MD-23-020)National Institute on Minority Health and Health Disparities
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Required)
(NOT-AG-23-050)National Institute on AgingNational Cancer InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and Stroke
Notices of Special Interest
-
Notice of Special Interest (NOSI): The Road to Prevention of Stillbirth
(NOT-HD-23-021)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Special Interest: Encouraging Small Businesses to Partner with Resource-Limited Institutions (RLIs) on Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program Applications
(NOT-OD-23-179)Office of the Director, NIH
Funding Opportunities
-
Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)
(PAR-23-221)National Institute of General Medical SciencesNational Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed)
(PAR-23-222)National Institute of General Medical SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Library of MedicineNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): Multiple dates, see announcement.
-
National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)
(PAR-23-228)National Institute of General Medical SciencesApplication Receipt Date(s): September 25, 2026
-
Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
(PAR-23-306)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsOffice of AIDS ResearchApplication Receipt Date(s): January 25, 2024
-
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
(PAR-23-308)National Cancer InstituteApplication Receipt Date(s): October 9, 2025
-
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
(PAR-24-037)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): March 13, 2026
-
Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed)
(RFA-CA-23-039)National Cancer InstituteApplication Receipt Date(s): December 5, 2023
-
Pre-Cancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed)
(RFA-CA-23-040)National Cancer InstituteApplication Receipt Date(s): December 5, 2023
-
Single Source: Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC; U24 Clinical Trial Not Allowed)
(RFA-CA-23-041)National Cancer InstituteApplication Receipt Date(s): December 5, 2023
-
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Basic Experimental Studies with Humans Required)
(RFA-DA-24-034)National Institute on Drug AbuseApplication Receipt Date(s): August 14, 2026
-
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R01 Clinical Trial Not Allowed)
(RFA-DA-25-011)National Institute on Drug AbuseApplication Receipt Date(s): September 10, 2024
-
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
(RFA-DA-25-059)National Institute on Drug AbuseApplication Receipt Date(s): October 14, 2024
-
Data Standards for Tobacco Research and Scientific Review Phase 2
(RFA-FD-24-001)Food and Drug AdministrationApplication Receipt Date(s): October 12, 2028
-
Career Enhancement Award to Advance the Study of Intimate Partner Violence (IPV) in the Context of Maternal Morbidity and Mortality Research (K18 Clinical Trial Not Allowed)
(RFA-OD-24-001)Office of Behavioral and Social Sciences ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Nursing ResearchOffice of Research on Women's HealthOffice of Disease PreventionApplication Receipt Date(s): December 1, 2023
-
R25 for Short Courses on Techniques for Measuring Intimate Partner Violence (IPV) in Different Populations (R25 Clinical Trial Not Allowed)
(RFA-OD-24-002)Office of Behavioral and Social Sciences ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Nursing ResearchOffice of Research on Women's HealthOffice of Disease PreventionApplication Receipt Date(s): December 1, 2023
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: January 24, 2025
For technical issues E-mail OER Webmaster